Clinical trial
Multicenter Observational Program Evaluation of the Efficacy and Tolerability of Detralex Treatment in Patients With Chronic Venous Edema (CEAP Class С3) in Real Clinical Practice
NCT03722836 is registered in ClinicalTrials.gov with Servier Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Observational Program Evaluation of the Efficacy and Tolerability of Detralex Treatment in Patients With Chronic Venous Edema (CEAP Class С3) in Real Clinical Practice
- Lead sponsor
- Servier Russia
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 6, 2018
- Completion date
- June 20, 2019
- Enrollment
- 708 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic venous disease